Abstract
The suitability of 4-di(2-chloroethyl)aminoanilino-4-hydroxyphenethylaminomethanone 2 to act as a prodrug for melanocyte-directed enzyme prodrug therapy (MDEPT) is assessed. Thus its synthesis, ability to generate a cytotoxic agent upon exposure to tyrosinase, and stability within different sera are reported. A comparison is made to illustrate that the new urea prodrug 2 is a more suitable candidate for MDEPT than the corresponding carbamate prodrug 1.
| Original language | English |
|---|---|
| Pages (from-to) | 2625-33 |
| Number of pages | 9 |
| Journal | Bioorganic and Medicinal Chemistry |
| Volume | 10 |
| Issue number | 8 |
| Publication status | Published - Aug 2002 |
Keywords
- Animals
- Blood
- Carbamates
- Cattle
- Cell Death
- Drug Delivery Systems
- Drug Stability
- Enzymes
- Humans
- Melanocytes
- Monophenol Monooxygenase
- Prodrugs
- Urea
Fingerprint
Dive into the research topics of 'Synthesis and analysis of urea and carbamate prodrugs as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver